ASH 2011 Conference Coverage
Drug is now sanctioned for people who have received at least two prior standard therapies.
Prostate cancer patients with detectable prostate specific antigen (PSA) following radical prostatectomy are advised to receive more aggressive radiation therapy treatment, according to a study.
Brain cancer is not increased by mobile phone use.
Black men are less willing to be investigated for prostate cancer, thereby increasing the likelihood of being diagnosed.
When active surveillance is chosen, survival for intermediate-risk disease may be decreased.
Women undergoing radiotherapy for breast cancer can use deodorant without increasing risk of underarm skin reactions, pain, itching, or burning.
How can patients find a qualified acupuncture practitioner who understands the needs of oncology patients?
Risk factors for suicide include male gender, distant disease, increasing age, race/ethnicity.
A previously unrecognized action as a potent inhibitor of the dominant mutation that confers drug resistance to all well-tolerated treatments in patients with certain leukemia types has been found in Axitinib.
A worldwide study of the DNA of 100,000 women has discovered two new genetic variants associated with an increased risk of breast cancer.
- Women educated on overdiagnsosis are less likely to want mammogram
- New treatment method shrinks ovarian cancer tumors and improves chemotherapy effectiveness
- Epigenetic signatures differentiate triple negative breast cancers
- Novel drug approved for multiple myeloma
- New mechanism of acquired resistance to breast cancer drugs discovered
- Patients with detectable PSA after prostatectomy should receive more aggressive radiation therapy
- Increase in brain tumors is not attributed to mobile phone use
- Black men have lower preference for investigation of prostate cancer
- ASCO: Active surveillance for prostate cancer may decrease survival odds for some
- Finding a qualified acupuncture practitioner
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|